Feb 26, 2019   SOURCE: PR NewsWire

Japan IVD Market Report 2019 - Sysmex Corporation is the Leader, Followed by Roche Diagnostics

DUBLIN, Feb. 26, 2019 /PRNewswire/ -- The "Japan IVD Market Size, Share, Major Deals & Company Analysis - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Japanese In Vitro Diagnostics (IVD) market is expected to surpass US$ 4.3 Billion mark by 2025

Japan represents one of the largest clinical laboratory markets in the Asia-Pacific region, and the fastest growing among the top ten IVD country markets. With an aging population, technological advances and advent of point of care diagnostics, Japanese IVD market is slated to show substantial growth in the future.

Japans quickly aging population means the country is experiencing an explosion of chronic conditions such as diabetes, heart disease and cancer. All of these conditions can be diagnosed and monitored using IVD products. However, some of the factors limiting the growth of the market are a lack of proper reimbursement policies and stringent regulatory framework.

Japan IVD Market Segment Wise Analysis

    --  On segment basis, Infectious disease and Immunoassay are the leading
        segment of the Japan IVD market.
    --  Clinical Chemistry holds the 3rd spot in the Japan IVD market.
    --  Hematology and Tumor Marker segments are competing closely with each
        other to grab maximum share of the pie.
    --  Pathology is the fastest growing segment of the Japan in vitro
        diagnostics market.
    --  Genetic Testing captures least share of the Japan in vitro diagnostics
        market.

Japan IVD Market Company Analysis

    --  In Japan IVD market, Sysmex Corporation is the leader, followed by Roche
        Diagnostics.
    --  It is predicted that Sysmex Corporation will maintain its dominant
        position throughout the forecasting period.
    --  Danaher Corporation and Abbott Laboratories are other top two players in
        the Japan IVD market.

    --  It is anticipated that biomerieux's IVD revenue in Japan will be close
        to US$ 190 Million by 2025.

This 128 Page report with 40 Figures and 4 Tables has been analyzed from 7 View Points:

    1. Japan IVD Market and Forecast (2002 - 2025)
    2. Japan IVD Market Share and Forecast (2008 - 2025)
    3. Japan IVD Market & Forecast - By Segment (2008 - 2025)
    4. Japan IVD Market & Forecast - Company Sales Analysis (2014 - 2025)
    5. Japan IVD Market - Major Deals
    6. Registration for In Vitro Diagnostic Devices in Japan
    7. Japan IVD Industry Drivers & Challenges

Key Topics Covered:

1. Executive Summary

2. Japan In-Vitro Diagnostics (IVD) Market and Market Share Analysis - Forecast to 2025
2.1 Japan IVD Market and Forecast (2002 - 2025)
2.2 By Segment - Japan IVD Market Share and Forecast (2008 - 2025)
2.3 By Company - Japan IVD Share and Forecast (2015 - 2025)

3. Japan IVD - Segments Wise Market and Forecast (2008 - 2025)
3.1 Urine & Feces Market and Forecast
3.2 Hematology Market and Forecast
3.3 Clinical Chemistry Market and Forecast
3.4 SMBG Market and Forecast
3.5 Tumor Marker Market and Forecast
3.6 Immunoassay Market and Forecast
3.7 Infectious disease Market and Forecast
3.8 Microbiology Market and Forecast
3.9 Pathology Market and Forecast
3.10 Genetic Testing Market and Forecast
3.11 Others Market and Forecast

4. Japan IVD Market - Company Wise Sales Analysis (2014 - 2025)
4.1 Roche Diagnostics
4.1.1 Business Overview
4.1.2 Roche Diagnostics - Japan IVD Sales and Forecast
4.1.3 Recent Initiatives/ Strategy/ Developments
4.2 Abbott Laboratories
4.3 Danaher Corporation
4.4 Biomerieux
4.5 Sysmex Corporation
4.6 Bio-Rad Laboratories, Inc
4.7 Becton Dickinson and Company
4.8 Others - Japan IVD Sales and Forecast

5. Japan IVD Market - Major Deals
5.1 2018
5.2 2017
5.3 2016

6. Japan IVD Market - Driving Factors
6.1 Technology Advancement Spurring the IVD Market
6.2 Increase in Geriatric Population
6.3 High Prevalence of Chronic and Infectious Diseases

7. Japan IVD Market - Challenges
7.1 Cumbersome Reimbursement Procedure
7.2 Stringent Regulatory Framework

For more information about this report visit https://www.researchandmarkets.com/research/gzbjk3/japan_ivd_market?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/japan-ivd-market-report-2019---sysmex-corporation-is-the-leader-followed-by-roche-diagnostics-300802162.html

SOURCE Research and Markets